Clinicopathological findings of choroidal neovascularisation following verteporfin photodynamic therapy

被引:23
|
作者
Gelisken, F
Lafaut, BA
Inhoffen, W
Voelker, M
Grisanti, S
Bartz-Schmidt, KU
机构
[1] Univ Tubingen, Dept Ophthalmol 1, D-72076 Tubingen, Germany
[2] State Univ Ghent, Dept Ophthalmol, Ghent, Belgium
关键词
D O I
10.1136/bjo.2003.018754
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aims: To report the clinicopathologic findings of surgically excised choroidal neovascularisation (CNV) three days after verteporfin photodynamic therapy (PDT). Methods: In three patients ( three eyes) with age related macular degeneration, the CNV was surgically removed three days after PDT. The CNV specimens were examined by light microscopy. Results: The patients had subfoveal classic CNV. Fluorescein angiography revealed non-perfusion of the CNV after PDT and before surgery in all eyes. The light microscopy of the CNV membranes showed swollen and damaged endothelium. Thrombus formation or vascular occlusion in the CNV vessels was not detected. Conclusion: PDT did not cause a thrombosis of the vessels within the CNV three days after PDT. Severe endothelial damage of the CNV was observed and is likely a primary effect of PDT. Non-perfusion of the CNV at this stage is possibly secondary to occlusion at a deeper level, namely the underlying feeding choroid.
引用
收藏
页码:207 / 211
页数:5
相关论文
共 50 条
  • [1] Verteporfin photodynamic therapy for choroidal neovascularisation in angioid streaks
    Browning, AC
    Amoaku, WM
    Chung, AKK
    Ghanchi, F
    Harding, SP
    Gee, L
    Musadiq, M
    Yang, YC
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U80 - U80
  • [2] Photodynamic therapy with verteporfin for choroidal neovascularisation associated with angioid streaks
    Heimann, H
    Gelisken, F
    Wachtlin, J
    Wehner, A
    Völker, M
    Foerster, MH
    Bartz-Schmidt, KU
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2005, 243 (11) : 1115 - 1123
  • [3] Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation in pathologic myopia
    Faik Gelisken
    Werner Inhoffen
    Alexander Hermann
    Salvatore Grisanti
    Karl Ulrich Bartz-Schmidt
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2004, 242 : 926 - 930
  • [4] Photodynamic therapy with verteporfin for choroidal neovascularisation associated with angioid streaks
    Heinrich Heimann
    Faik Gelisken
    Joachim Wachtlin
    Andreas Wehner
    Michael Völker
    Michael H. Foerster
    Karl Ulrich Bartz-Schmidt
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2005, 243 : 1115 - 1123
  • [5] Verteporfin (Visudyne) based photodynamic therapy for subfoveal choroidal neovascularisation
    Saperstein, DA
    Rosenfeld, PJ
    Rosa, R
    Sickenberg, M
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S176 - S176
  • [6] Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation
    Montero, JA
    Ruiz-Moreno, JM
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2003, 87 (02) : 173 - 176
  • [7] Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation in pathologic myopia
    Gelisken, F
    Inhoffen, W
    Hermann, A
    Grisanti, S
    Bartz-Schmidt, KU
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2004, 242 (11) : 926 - 930
  • [8] Photodynamic therapy with verteporfin for recurrent choroidal neovascularisation following prior argon laser coagulation
    Gabel-Pfisterer, A
    Wehner, A
    Heimann, H
    Foerster, MH
    Wachtlin, J
    OPHTHALMOLOGE, 2005, 102 (06): : 592 - 596
  • [9] Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularisation secondary to pathological myopia
    Gibson, J
    EYE, 2005, 19 (08) : 829 - 830
  • [10] Outcomes in verteporfin photodynamic therapy for choroidal neovascularisation - 'beyond the TAP study'
    Barnes, RM
    Gee, L
    Taylor, S
    Briggs, MC
    Harding, SP
    EYE, 2004, 18 (08) : 809 - 813